CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and prima...
Phase 3
Charlotte, North Carolina, United States and 22 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Charlotte, North Carolina, United States and 176 other locations
Phase 1 trial to study the safety, pharmacokinetics and preliminary efficacy of STRO-002 given intravenously every 3 weeks.
Phase 1
Charlotte, North Carolina, United States and 26 other locations
Ovarian cancer is a heterogeneous disease, characterized by complex molecular and genetic changes. The high expression of vascular ...
Phase 3
Charlotte, North Carolina, United States and 189 other locations
The primary objective is to compare pembrolizumab plus paclitaxel with or without bevacizumab to placebo plus paclitaxel with or without bevacizumab,...
Phase 3
Charlotte, North Carolina, United States and 186 other locations
This proposed Phase I clinical trial of SON-DP is an FIH, open-label, Phase Ia/Ib dose escalation and expansion study to evaluate the safety, tolerab...
Phase 1
Huntersville, North Carolina, United States and 4 other locations
Dose (RP2D) in patients with ovarian cancer, and Part C will evaluate combination treatment of INX-315 plus a CDK4/6i and selectiv...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 6 other locations
This is a Phase 1, multicenter, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and prel...
Phase 1
Huntersville, North Carolina, United States and 9 other locations
(with enzalutamide-naïve metastatic castration-resistant prostate cancer) will be randomized to receive either NUV-868 monotherapy, enzaluta...
Phase 1, Phase 2
Huntersville, North Carolina, United States and 31 other locations
, metastatic castration-resistant prostate cancer (mCRPC), melanoma, pancreatic cancer, hepatocellular carcinoma (HCC), ovarian...
Phase 1
Huntersville, North Carolina, United States and 9 other locations
Clinical trials
Research sites
Resources
Legal